Zymeworks BC Inc’s filing revealed that its EVP & Chief Medical Officer Smith Jeffrey T L unloaded Company’s shares for reported $0.26 million on Jan 05 ’26. In the deal valued at $25.10 per share,10,538 shares were sold. As a result of this transaction, Smith Jeffrey T L now holds 18,352 shares worth roughly $0.44 million.
Then, Galbraith Kenneth sold 54,343 shares, generating $1,363,841 in total proceeds. Upon selling the shares at $25.10, the Chair & CEO now owns 158,286 shares.
Before that, Moore Paul Andrew sold 20,110 shares. Zymeworks BC Inc shares valued at $504,699 were divested by the Chief Scientific Officer at a price of $25.10 per share. As a result of the transaction, Moore Paul Andrew now holds 31,212 shares, worth roughly $0.75 million.
Wells Fargo upgraded its Zymeworks BC Inc [ZYME] rating to an Overweight from a an Equal weight in a research note published recently. A number of analysts have revised their coverage, including Citizens JMP’s analysts, who began to cover the stock in early December with a ‘”a Mkt outperform”‘ rating. H.C. Wainwright revised its rating on October 14, 2025. It rated ZYME as “a Buy” which previously was an “a Neutral”.
Price Performance Review of ZYME
On Tuesday, Zymeworks BC Inc [NASDAQ:ZYME] saw its stock fall -5.10% to $24.18. Over the last five days, the stock has lost -9.57%. Zymeworks BC Inc shares have risen nearly 63.60% since the year began. Nevertheless, the stocks have fallen -8.17% over the past one year. While a 52-week high of $28.49 was reached on 01/05/26, a 52-week low of $9.03 was recorded on 01/06/26.
Levels Of Support And Resistance For ZYME Stock
The 24-hour chart illustrates a support level at 23.49, which if violated will result in even more drops to 22.79. On the upside, there is a resistance level at 25.10. A further resistance level may holdings at 26.01.
How much short interest is there in Zymeworks BC Inc?
A steep rise in short interest was recorded in Zymeworks BC Inc stocks on 2025-12-15, dropping by -4.6 million shares to a total of 3.94 million shares. Yahoo Finance data shows the prior-month short interest on 2025-11-14 was 8.54 million shares. There was a decline of -116.85%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on October 10, 2025 when B. Riley Securities began covering the stock and recommended ‘”a Buy”‘ rating along with a $30 price target.
